Open-Systems-Pharmacology / Ketoconazole-Alfentanil-DDI

Geek Repo:Geek Repo

Github PK Tool:Github PK Tool

Ketoconazole-Alfentanil-DDI

Modeling of published clinical ketoconazole-alfentanil DDI studies for model evaluation

Repository files

Within this repository, we distribute a PK-Sim project file containing simulations of the published clinical studies used to evaluate the predictive performance of the ketoconazole model [1] regarding the DDI with the CYP3A4 victim drug alfentanil, including the respective observed data digitized from literature reports. The applied alfentanil model has been published previously [2]. For further details and documentation please refer to [1].

Version information

PK-Sim Version 11.0.

Code of conduct

Everyone interacting in the Open Systems Pharmacology community (codebases, issue trackers, chat rooms, mailing lists etc...) is expected to follow the Open Systems Pharmacology code of conduct.

Contribution

We encourage contribution to the Open Systems Pharmacology community. Before getting started please read the contribution guidelines. If you are contributing code, please be familiar with the coding standard.

License

The model is distributed under the GPLv2 Lincense.

Reference

[1] Marok, F.Z.; Wojtyniak, J.-G.; Fuhr, L.M.; Selzer, D.; Schwab, M.; Weiss, J.; Haefeli, W.E.; Lehr, T. A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug–Drug Interaction Perpetrators. Pharmaceutics 2023, 15, 679. https://doi.org/10.3390/pharmaceutics15020679

[2] Hanke N, Frechen S, Moj D, Britz H, Eissing T, Wendl T, Lehr T. PBPK Models for CYP3A4 and P-gp DDI prediction: A modeling network of rifampicin, itraconazole, clarithromycin, midazolam, alfentanil, and digoxin. CPT Pharmacometrics Syst. Pharmacol. 2018; 7, 647–659